Cargando…
Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study
We assessed the effect of a 2-year supplementation with a highly concentrated docosahexaenoic acid (DHA) product with antioxidant activity on non-proliferative diabetic retinopathy (NPDR) in a randomized double-blind placebo-controlled study. A total of 170 patients with diabetes were randomly assig...
Autores principales: | Piñas García, Purificación, Hernández Martínez, Francisco Javier, Aznárez López, Núria, Castillón Torre, Luis, Tena Sempere, Mª Eugenia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772895/ https://www.ncbi.nlm.nih.gov/pubmed/35052620 http://dx.doi.org/10.3390/antiox11010116 |
Ejemplares similares
-
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial
por: Arellanes, Isabella C., et al.
Publicado: (2020) -
Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial
por: Ayats-Vidal, Roser, et al.
Publicado: (2023) -
Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review
por: Lafuente, María, et al.
Publicado: (2021) -
Prenatal choline supplementation improves biomarkers of maternal docosahexaenoic acid (DHA) status among pregnant participants consuming supplemental DHA: a randomized controlled trial
por: Klatt, Kevin C, et al.
Publicado: (2022) -
Prenatal Maternal Docosahexaenoic Acid (DHA) Supplementation and Newborn Anthropometry in India: Findings from DHANI
por: Khandelwal, Shweta, et al.
Publicado: (2021)